AbbVie Inc. (ABBV) vs Monster Beverage Corporation (MNST)
A side-by-side comparison of AbbVie Inc. and Monster Beverage Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; MNST is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
MNST
Monster Beverage Corporation
$97.74Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs MNST
growth of $100 · dividends reinvested · last 14yABBV +1164.7%MNST +982.1%ABBV compounded faster
ABBV MNST
ABBV vs MNST: by the numbers
- •ABBV is the larger company ($465.51B vs $95.59B market cap).
- •MNST trades at the lower trailing earnings multiple (46.05 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •MNST converts more revenue to profit (23.11% vs 5.79% net margin).
- •MNST grew revenue faster over the past five years (12.96% vs 4.59% CAGR).
- •ABBV pays a dividend (2.62% yield), while MNST is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | ABBV | MNST |
|---|---|---|
| P/E ratio | 125.98 | 46.05 |
| Forward P/E | N/A | 41.41 |
| P/S ratio | 7.26 | 10.71 |
| P/B ratio | 16.57 | 10.80 |
| PEG ratio | N/A | 1.31 |
| EV / EBITDA | 20.46 | 34.17 |
| FCF yield | 4.58% | 2.20% |
Profitability
| Metric | ABBV | MNST |
|---|---|---|
| Gross margin | 70.68% | 55.47% |
| Operating margin | 27.60% | 29.34% |
| Net margin | 5.79% | 23.11% |
| ROE | 13.23% | 23.28% |
| ROIC | 12.97% | 21.74% |
Dividends
| Metric | ABBV | MNST |
|---|---|---|
| Dividend yield | 2.62% | N/A |
| Payout ratio | 284.39% | N/A |
Growth (annualized)
| Metric | ABBV | MNST |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 12.96% |
| EPS CAGR (5Y) | -2.79% | 7.95% |
| FCF CAGR (5Y) | 3.24% | 10.53% |
| Total return CAGR (5Y) | 21.24% | 14.91% |
Frequently asked
- Which has the lower trailing P/E, ABBV or MNST?
- MNST has the lower trailing P/E: ABBV trades at 125.98 and MNST at 46.05. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or MNST?
- Over the past five years, MNST grew revenue faster — ABBV at a 4.59% CAGR versus MNST at 12.96%.
- Does ABBV or MNST pay a bigger dividend?
- ABBV pays a dividend (2.62% yield), while MNST is a former payer with no current dividend run rate.
- Is ABBV or MNST more profitable?
- MNST runs the higher net margin — ABBV at 5.79% versus MNST at 23.11%.
- How have ABBV and MNST total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and MNST delivered 13.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioMonster Beverage P/E ratioAbbVie dividend yieldMonster Beverage dividend yieldAbbVie ROEMonster Beverage ROEAbbVie operating marginMonster Beverage operating marginAbbVie revenue growthMonster Beverage revenue growthAbbVie free cash flowMonster Beverage free cash flow
AbbVie & Monster Beverage appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.